Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-010914
Filing Date
2013-02-20
Accepted
2013-02-20 16:05:27
Documents
1
Period of Report
2013-02-19

Document Format Files

Seq Description Document Type Size
1 INITIAL STOCK GRANT - FEB 19, 2013 rrd370995.html 4  
1 INITIAL STOCK GRANT - FEB 19, 2013 rrd370995.xml 4 5951
  Complete submission text file 0001181431-13-010914.txt   7297
Mailing Address 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address 4 MAGUIRE ROAD LEXINGTON MA 02421 617-503-6500
CURIS INC (Issuer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CURIS, INC. 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address
Fattaey Ali Ph.D. (Reporting) CIK: 0001570026 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30347 | Film No.: 13626786